Impairment of FOS mRNA induction by a translation inhibitor puromycin in granulocytes from myelodysplastic syndrome patients

Br J Haematol. 2011 Aug;154(4):525-7. doi: 10.1111/j.1365-2141.2010.08504.x. Epub 2011 Apr 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Gene Expression Regulation / drug effects
  • Granulocytes / drug effects*
  • Humans
  • Myelodysplastic Syndromes / blood*
  • Protein Synthesis Inhibitors / pharmacology*
  • Proto-Oncogene Proteins c-fos / biosynthesis*
  • Puromycin / pharmacology*
  • RNA, Messenger / genetics

Substances

  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Puromycin